Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Caffeine stimulates central nervous system on a short term. However, the long-term impact of caffeine on cognition remains unclear. We aimed to study the association between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life. Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit). After an average follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examination in 1998. A total of 61 cases were identified as demented (48 with AD). Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demographic, lifestyle and vascular factors, apolipoprotein E epsilon4 allele and depressive symptoms. The lowest risk (65% decreased) was found in people who drank 3-5 cups per day. Tea drinking was relatively uncommon and was not associated with dementia/AD. Coffee drinking at midlife is associated with a decreased risk of dementia/AD later in life. This finding might open possibilities for prevention of dementia/AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“though this was found only for coffee intake in two studies [165,169]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [165]
In the citing paper
“while 5 recent studies detected this association only among women or for specific exposures [165,169,171-173]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [165]
In the citing paper
“Finally, large cohort studies of men and women have also found an inverse relationship between caffeine consumption and the risk of Parkinson’s disease (90–92) and Alzheimer’s disease (93–95).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [94]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“Caffeine is a nonselective A1 and A2a adenosine receptor antagonist, and thereby it stimulates cholinergic neurons [31].”
WHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,794
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 3×
“The results are in accordance with previous report from the CSHA study [2] in the elderly, and now extend the effects to”
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Self-citationAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Effects of caffeine on human behavior
Smith, A. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00096-0 · Cited by 741 · cited 1×
“While short-term central nervous system stimulating effects of caffeine are well known [1], the longterm impact remains unclear.”
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717 · cited 1×
“A more detailed description of the sampling has been described earlier [17] [18] .”
Self-citation
Cited by
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
“dementia/AD later in life [269].”
Alzheimer’s disease and gut microbiota
Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 357
O'Keefe, J. H., Bhatti, S. K., Patil, H. R., DiNicolantonio, J. J., Lucan, S. C., & Lavie, C. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.035 · Cited by 354
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Glade, M. J. (2010) · Nutrition · doi:10.1016/j.nut.2010.08.004 · Cited by 306
The neuroprotective effects of caffeine in neurodegenerative diseases
Kolahdouzan, M., & Hamadeh, M. J. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12684 · Cited by 302
Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
Eskelinen, M. H., & Kivipelto, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1404 · Cited by 259
Self-citationLymphatic drainage system of the brain: A novel target for intervention of neurological diseases
Sun, B.-L., Wang, L.-H., Yang, T., Sun, J.-Y., Mao, L.-L., Yang, M.-F., Yuan, H., Colvin, R. A., & Yang, X.-Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.007 · Cited by 255
Neuroprotective Effects of Coffee Bioactive Compounds: A Review
Socała, K., Szopa, A., Serefko, A., Poleszak, E., & Wlaź, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010107 · Cited by 248
Mancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1408 · Cited by 232
Health Benefits of Methylxanthines in Cacao and Chocolate
Franco, R., Oñatibia-Astibia, A., & Martínez-Pinilla, E. (2013) · Nutrients · doi:10.3390/nu5104159 · Cited by 228
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J.-T., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 225
Caffeine Consumption through Coffee: Content in the Beverage, Metabolism, Health Benefits and Risks
dePaula, J., & Farah, A. (2019) · Beverages · doi:10.3390/beverages5020037 · Cited by 222
Di Marco, L. Y., Marzo, A., Muñoz-Ruiz, M., Ikram, M. A., Kivipelto, M., Ruefenacht, D., Venneri, A., Soininen, H., Wanke, I., Ventikos, Y. A., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132225 · Cited by 215
“, [58, 61, 82]), or both systolic and diastolic blood pressure values (e.”
Self-citationNutrition and the Risk of Alzheimer's Disease
Hu, N., Yu, J.-T., Tan, L., Wang, Y.-L., Sun, L., & Tan, L. (2013) · BioMed Research International · doi:10.1155/2013/524820 · Cited by 209
Caffeine and Coffee as Therapeutics Against Alzheimer's Disease
Arendash, G. W., & Cao, C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091249 · Cited by 201
The influence of beverage composition on delivery of phenolic compounds from coffee and tea
Ferruzzi, M. G. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.01.035 · Cited by 198
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Müller, C. E., Buée, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.027 · Cited by 195
Panza, F., Solfrizzi, V., Barulli, M. R., Bonfiglio, C., Guerra, V., Osella, A., Seripa, D., Sabbà, C., Pilotto, A., & Logroscino, G. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0563-8 · Cited by 194
Caffeine Intake and Dementia: Systematic Review and Meta-Analysis
Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., & Lunet, N. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091387 · Cited by 192
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
“[58] also studied the association between caffeine intake and AD and dementia.”
BackgroundMonteiro, J., Alves, M., Oliveira, P., & Silva, B. (2016) · Molecules · doi:10.3390/molecules21080974 · Cited by 182
Temido-Ferreira, M., Ferreira, D. G., Batalha, V. L., Marques-Morgado, I., Coelho, J. E., Pereira, P., Gomes, R., Pinto, A., Carvalho, S., Canas, P. M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0110-9 · Cited by 179
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
IJzerman, A. P., Jacobson, K. A., Müller, C. E., Cronstein, B. N., & Cunha, R. A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000445 · Cited by 179
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Ren, X., & Chen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602697 · Cited by 178
Caffeine and Its Antioxidant Properties—It Is All about Dose and Source
Ősz, B.-E., Jîtcă, G., Ștefănescu, R., Puşcaş, A., Tero-Vescan, A., & Vari, C.-E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113074 · Cited by 177
Noguchi-Shinohara, M., Yuki, S., Dohmoto, C., Ikeda, Y., Samuraki, M., Iwasa, K., Yokogawa, M., Asai, K., Komai, K., Nakamura, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096013 · Cited by 174
Nutritional prevention of cognitive decline and dementia.
Dominguez, L. J., & Barbagallo, M. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i2.7401 · Cited by 166
Lafortune, L., Martin, S., Kelly, S., Kuhn, I., Remes, O., Cowan, A., & Brayne, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0144405 · Cited by 165
Matos, M., Augusto, E., Machado, N. J., dos Santos-Rodrigues, A., Cunha, R. A., & Agostinho, P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120469 · Cited by 130
Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?
Perry, E., & Howes, M. R. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00202.x · Cited by 160
Espinosa, J., Rocha, A., Nunes, F., Costa, M. S., Schein, V., Kazlauckas, V., Kalinine, E., Souza, D. O., Cunha, R. A., & Porciúncula, L. O. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-111982 · Cited by 143
Alzheimer's disease and diet: a systematic review
Yusufov, M., Weyandt, L. L., & Piryatinsky, I. (2017) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1155572 · Cited by 140
Li, P., Rial, D., Canas, P. M., Yoo, J.-H., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.182 · Cited by 140
Wu, M.-S., Lan, T.-H., Chen, C.-M., Chiu, H.-C., & Lan, T.-Y. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-22 · Cited by 133
Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants
Franzoni, F., Scarfò, G., Guidotti, S., Fusi, J., Асомов, М. И., & Pruneti, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.729757 · Cited by 156
Adenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 152
Chen, X., Ghribi, O., & Geiger, J. D. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1376 · Cited by 132
The Medicinal Chemistry of Caffeine
Faudone, G., Arifi, S., & Merk, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00261 · Cited by 150
High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia
Cao, C., Loewenstein, D. A., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111781 · Cited by 133
Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
“A population-based study reported that drinking of 3–5 cups of coffee per day might reduce the incidence of AD and dementia by 65% (Eskelinen et al., 2009).”
BackgroundNeuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases
Chen, S.-Q., Wang, Z.-S., Ma, Y.-X., Zhang, W., Lu, J.-L., Liang, Y.-R., & Zheng, X.-Q. (2018) · Molecules · doi:10.3390/molecules23030512 · Cited by 132
Advances in the prevention of Alzheimer's Disease
Sindi, S., Mangialasche, F., & Kivipelto, M. (2015) · F1000Prime Reports · doi:10.12703/p7-50 · Cited by 109
Self-citationCurrent therapeutic targets for the treatment of Alzheimer’s disease
Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 121
Liu, Q., Wu, Y., Cheng, H., Xia, T., Ding, H., Wang, H., Wang, Z., & Xu, Y. (2016) · Nutrition · doi:10.1016/j.nut.2015.11.015 · Cited by 134
Ruusunen, A., Lehto, S. M., Tolmunen, T., Mursu, J., Kaplan, G. A., & Voutilainen, S. (2010) · Public Health Nutrition · doi:10.1017/s1368980010000509 · Cited by 119
Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates
Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101428 · Cited by 133
Balakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I., & Choi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6680935 · Cited by 133
Caffeine, Adenosine Receptors, and Synaptic Plasticity
Costenla, A. R., Cunha, R. A., & de Mendonça, A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091384 · Cited by 132
Bommakanti, V., Ajikumar, A. P., Sivi, C., Prakash, G., Shanker, M. A., Ahmad, F., Haque, S., Prieto, M. A., & Rana, S. (2023) · Separations · doi:10.3390/separations10030177 · Cited by 132
Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria
Schaffer, S., Asseburg, H., Kuntz, S., Muller, W. E., & Eckert, G. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8282-9 · Cited by 131
Trinh, K., Andrews, L., Krause, J., Hanak, T., Lee, D., Gelb, M., & Pallanck, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4777-09.2010 · Cited by 114
Chlorogenic acid, a polyphenol in coffee, protects neurons against glutamate neurotoxicity
Mikami, Y., & Yamazawa, T. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.08.005 · Cited by 127
Chan, S., Kantham, S., Rao, V. M., Palanivelu, M. K., Pham, H. L., Shaw, P. N., McGeary, R. P., & Ross, B. P. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2015.11.118 · Cited by 124
Bioappearance and pharmacokinetics of bioactives upon coffee consumption
Lang, R., Dieminger, N., Beusch, A., Lee, Y., Dunkel, A., Suess, B., Skurk, T., Wahl, A., Hauner, H., & Hofmann, T. F. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7288-0 · Cited by 122
Pharmacological potential of methylxanthines: Retrospective analysis and future expectations
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1461607 · Cited by 121
Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119
Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease
Camandola, S., Plick, N., & Mattson, M. P. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2492-0 · Cited by 119
The Role of Adenosine in Alzheimers Disease
Rahman, A. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152119 · Cited by 118
Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives
Ide, K., Matsuoka, N., Yamada, H., Furushima, D., & Kawakami, K. (2018) · Molecules · doi:10.3390/molecules23092357 · Cited by 102
Haskell-Ramsay, C. F., Jackson, P. A., Forster, J. S., Dodd, F. L., Bowerbank, S. L., & Kennedy, D. O. (2018) · Nutrients · doi:10.3390/nu10101386 · Cited by 95
Caffeine attenuates lipopolysaccharide-induced neuroinflammation
Brothers, H. M., Marchalant, Y., & Wenk, G. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.013 · Cited by 115
Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111
Wu, L., Sun, D., & He, Y. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.05.015 · Cited by 110
Adenosine A 2 A receptors are necessary and sufficient to trigger memory impairment in adult mice
Pagnussat, N., Almeida, A. S., Marques, D. M., Nunes, F., Chenet, G. C., Botton, P. H. S., Mioranzza, S., Loss, C. M., Cunha, R. A., & Porciúncula, L. O. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13180 · Cited by 108
Amato, A., Terzo, S., & Mulè, F. (2019) · Antioxidants · doi:10.3390/antiox8120608 · Cited by 107
“Epidemiological study Coffee Lower risk of dementia and AD later in life [120].”
BackgroundNatural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107
Fischer, K., van Lent, D. M., Wolfsgruber, S., Weinhold, L., Kleineidam, L., Bickel, H., Scherer, M., Eisele, M., van den Bussche, H., Wiese, B., et al. (2018) · Nutrients · doi:10.3390/nu10070852 · Cited by 107
Grant, W. B. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130719 · Cited by 92
Adenosine and Related Drugs in Brain Diseases: Present and Future in Clinical Trials
Lopes, L. V., Sebastião, A. M., & Ribeiro, J. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347591 · Cited by 106
Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
Santos, C., Lunet, N., Azevedo, A., de Mendonça, A., Ritchie, K., & Barros, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091303 · Cited by 100
“The results obtained are in agreement with several previously reports which suggested that caffeine reduces the risk of dementia or cognitive decline [7,8,11, 12,40].”
Arab, L., Biggs, M. L., O'Meara, E. S., Longstreth, W. T., Crane, P. K., & Fitzpatrick, A. L. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110431 · Cited by 98
Quercetin, not caffeine, is a major neuroprotective component in coffee
Lee, M., McGeer, E. G., & McGeer, P. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.015 · Cited by 98
Silva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 95
Larsson, S. C., & Orsini, N. (2018) · Nutrients · doi:10.3390/nu10101501 · Cited by 94
Chen, J., & Chern, Y. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_10 · Cited by 92
Cao, C., Wang, L., Lin, X., Mamcarz, M., Zhang, C., Bai, G., Nong, J., Sussman, S., & Arendash, G. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110110 · Cited by 75
Coffee intake and decreased amyloid pathology in human brain
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Jung, G., Lee, H. N., Sohn, B. K., Lee, J.-Y., Kim, Y. K., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0604-5 · Cited by 86
Carman, A. J., Dacks, P. A., Lane, R. F., Shineman, D. W., & Fillit, H. M. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0021-7 · Cited by 85
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
Liu, J., Supnet, C., Sun, S., Zhang, H., Good, L., Popugaeva, E., & Bezprozvanny, I. (2014) · Channels · doi:10.4161/chan.27471 · Cited by 77
Alferink, L. J. M., Fittipaldi, J., Jong, J. C. K., Taimr, P., Hansen, B. E., Metselaar, H. J., Schoufour, J. D., Ikram, M. A., Janssen, H. L. A., Franco, O. H., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.013 · Cited by 84
Gut Microbiota in Neurological Disorders
Grochowska, M., Laskus, T., & Radkowski, M. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00561-6 · Cited by 83
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saito, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 73
Tea drinking and cognitive function in oldest-old Chinese
Feng, L., Li, J., Ng, T.-P., Lee, T.-S., Kua, E.-H., & Zeng, Y. (2012) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0077-1 · Cited by 82
“There is evidence from a Finnish cohort study to suggest that midlife coffee consumption was related to reduced dementia risk (17).”
BackgroundFukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 82
Plant Foods Rich in Antioxidants and Human Cognition: A Systematic Review
Baroni, L., Sarni, A. R., & Zuliani, C. (2021) · Antioxidants · doi:10.3390/antiox10050714 · Cited by 82
Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study
Paganini-Hill, A., Kawas, C. H., & Corrada, M. M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000087 · Cited by 71
Ide, K., Yamada, H., Takuma, N., Kawasaki, Y., Harada, S., Nakase, J., Ukawa, Y., & Sagesaka, Y. M. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0168-7 · Cited by 68
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 67
Alcohol, coffee and tea intake and the risk of cognitive deficits: a dose–response meta-analysis
Ran, L. S., Liu, W. H., Fang, Y. Y., Xu, S. B., Li, J., Luo, X., Pan, D. J., Wang, M. H., & Wang, W. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020001183 · Cited by 69
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders
Ngowi, E. E., Wang, Y., Qian, L., Helmy, Y. A. S. H., Anyomi, B. K., Li, T., Zheng, M., Jiang, E., Duan, S., Wei, J., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.629832 · Cited by 77
Metadata
- Authors
- Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M.
- Affiliations
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-01-04
- Volume
- 16
- Issue
- 1
- Pages
- 85-91
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2149637082
- Cited by
- 428
- References
- 38
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 31 · 2023: 30 · 2022: 27 · 2021: 36 · 2020: 25 · 2019: 18 · 2018: 30 · 2017: 21 · 2016: 32 · 2015: 25 · 2014: 35 · 2013: 25 · 2012: 18
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Academy of Finland
- Kuopion Yliopistollinen Sairaala
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- coffee consumption, tea consumption
- MeSH terms
- Aged, Apolipoproteins E, Coffee, Cognition, Data Interpretation, Statistical, Dementia, Diet, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Population, Risk, Risk Factors, Smoking, Tea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.